A statement was made elsewhere, where it was pointed
A statement was made elsewhere, where it was pointed out...
Quote:
The key to disrupting viral envelopes and bacterial membranes (and cancer cells) seems to be the relative negative charges they have, but our cells don't, such that the cationic small molecule defensin mimetic drugs can kill the bad guys, not the good guys.
...and it is KEY!
As I recall...the mechanism you describe...appears to be exactly what Dr. DeGrado and the Polymedix team observed as supporting the efficacy of Brilacidin through this mechanism you describe and producing the destruction of both Bacteria and Virus envelope cells...by Brilacidin...
There was commentary in Polymedix PR's and conferences... that Brilacidin was designed to attract negatively charged envelope cells...and upon contact "pop them, like a pin pops a balloon"...but it is not a "by chance" contact with the cells and their destruction would occur...
The two (Brilacidin and Envelope Bacteria/Viral Cells) in "proximity" of one another, causes a "magnetic" effect...between the targeted cells (bacterial or viral cells) to be destructed and Brilacidin, i.e. bad cells are "attracted" to Brilacidin.
Add to that...the Systemic IV delivery (especially 5 days in a row)...IMO can show in the Clinical Trials...a very dramatic effect significant efficacy against Covid-19 and its Variants (Russia had Delta Variant toward the end of trials)...
We should not be surprised and should not forget that...Brilacidin was "INTENTIONALLY DESIGNED" to work as described in the above...it just wasn't "Discovered" to possibly do it.
Additionally, with Brilacidin's superior SI, I would not be surprised if we learn that the DAILY DOSAGE (given 5 days in a row...for 75% of the patients) of Brilacidin/Covid-19 was the same as the ABSSSI Trials...which demonstrated superior efficacy over the SOC with only ONE IV DOSE.
In other words... with Brilacidin SI so high...it would not be surprising that the FDA would "let it rip" against Covid-19.
We will soon know the results! Keep smiling!
...and KNOW WHAT YOU OWN!
18
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...
Continue Reading
A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...
Continue Reading
WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...
Continue Reading
Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...
Continue Reading
A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...
Continue Reading
Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....
Continue Reading
Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...
Continue Reading
A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...
Continue Reading
If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...
Continue Reading
Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...
Continue Reading
Top 5 Most Recently Viewed Articles
Pegascape to Success: A New Peak for Pegasystems Inc. Pegasystems Inc. (NASDAQ: PEGA), a frontrunner in cloud computing for customer engagement and operational excellence, has reached a standout milestone, with its stock price climbing to a remarkable 52-week high of $91.58. This achievement reflects significant investor confidence, with a whopping 75.11% increase in...
Continue Reading
Understanding Upcoming Solvency Reforms in the UK Upcoming reforms to the U.K. solvency regulations are anticipated to bring significant changes that will positively impact life insurers throughout the market. A recent report from AM Best delves into the nuances of these reforms, expected to be outlined in detail soon. What the Reforms Entail The newly anticipated...
Continue Reading
Transformative Growth of $100 Investment in Sterling Infrastructure Sterling Infrastructure (NASDAQ: STRL) has shown remarkable performance over the last decade, achieving an impressive annual return that exceeds market averages. In fact, the company has outshined the market by approximately 34.82% on an annualized basis, yielding an average annual return of about 47.54%....
Continue Reading
SYNEVIT®: A Commitment to Health for the Holidays Aligning Long-Term Health With Trends in Younger Generations This holiday season, health-conscious consumers are more aware than ever of their wellness needs. With interest in wellness rapidly evolving, SYNEVIT® takes center stage by offering high-quality, science-backed nutraceuticals tailored for younger individuals...
Continue Reading
Gotham's Innovative Growth Accelerator for Black-Owned Brands Gotham, a pioneering name in the cannabis retail space, has recently introduced a groundbreaking initiative known as the Gotham Growth Project (GGP). This program is set to uplift growth-stage cannabis consumer brands that hail from underserved communities, with a primary focus on Black-owned businesses. The...
Continue Reading